---
DrugClass: "[[Immune Modulating Therapies]]"
SubClass: "[[Checkpoint inhibitors]]"
DrugClassAdverse: "[[Checkpoint inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Checkpoint inhibitors#Contraindications]]"
BrandName: Calquence
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "51"
KindleLinkChap: "[Chapter 51](kindle://book?action=open&asin=B09FRF11YJ&location=30282)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Tyrosine Kinase/EGFR Inhibitors
---

```smiles
CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
[[Leukemia]]/[[Lymphoma]] 


### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action
- [Tyrosine-protein kinase BTK](https://go.drugbank.com/drugs/DB11703#BE0001284)
    
    Inhibitor

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Fatigue, nausea, vomiting, diarrhea, constipation, [[Vision]] problems 

### Interactions

`= this.ChemLink+this.file.name`

